ES551451A0 - Procedimiento para la obtencion de furanonas. - Google Patents

Procedimiento para la obtencion de furanonas.

Info

Publication number
ES551451A0
ES551451A0 ES551451A ES551451A ES551451A0 ES 551451 A0 ES551451 A0 ES 551451A0 ES 551451 A ES551451 A ES 551451A ES 551451 A ES551451 A ES 551451A ES 551451 A0 ES551451 A0 ES 551451A0
Authority
ES
Spain
Prior art keywords
increase
furanonas
procedure
obtaining
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551451A
Other languages
English (en)
Other versions
ES8701746A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8701746A1 publication Critical patent/ES8701746A1/es
Publication of ES551451A0 publication Critical patent/ES551451A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
ES551451A 1984-05-03 1986-01-30 Procedimiento para la obtencion de furanonas. Expired ES8701746A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416293 DE3416293A1 (de) 1984-05-03 1984-05-03 Annellierte furanone, verfahren zu ihrer herstellun g und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8701746A1 ES8701746A1 (es) 1986-12-01
ES551451A0 true ES551451A0 (es) 1986-12-01

Family

ID=6234834

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542564A Expired ES8607270A1 (es) 1984-05-03 1985-04-25 Furanonas
ES551452A Expired ES8702396A1 (es) 1984-05-03 1986-01-30 Procedimiento para la obtencion de furanonas.
ES551451A Expired ES8701746A1 (es) 1984-05-03 1986-01-30 Procedimiento para la obtencion de furanonas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES542564A Expired ES8607270A1 (es) 1984-05-03 1985-04-25 Furanonas
ES551452A Expired ES8702396A1 (es) 1984-05-03 1986-01-30 Procedimiento para la obtencion de furanonas.

Country Status (9)

Country Link
US (2) US4668691A (es)
EP (1) EP0160256B1 (es)
JP (1) JPH0647584B2 (es)
KR (1) KR850008673A (es)
AT (1) ATE37545T1 (es)
CA (1) CA1259073A (es)
DE (2) DE3416293A1 (es)
ES (3) ES8607270A1 (es)
HU (1) HU194202B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1296010C (en) * 1985-12-16 1992-02-18 Patrick F. King Di- and triarylurethane dye precursors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3702853A (en) * 1970-01-13 1972-11-14 Syntex Corp Certain 5-substituted tetrahydroiso-benzofuran-1-ones
US4491667A (en) * 1981-06-17 1985-01-01 Hitachi Chemical Company, Ltd. Hexahydrophthalides

Also Published As

Publication number Publication date
ATE37545T1 (de) 1988-10-15
US4762853A (en) 1988-08-09
DE3565263D1 (en) 1988-11-03
ES8702396A1 (es) 1986-12-16
ES8701746A1 (es) 1986-12-01
JPS60239479A (ja) 1985-11-28
KR850008673A (ko) 1985-12-21
JPH0647584B2 (ja) 1994-06-22
EP0160256B1 (de) 1988-09-28
ES551452A0 (es) 1986-12-16
HU194202B (en) 1988-01-28
HUT38096A (en) 1986-04-28
ES542564A0 (es) 1986-05-16
EP0160256A2 (de) 1985-11-06
DE3416293A1 (de) 1985-11-07
CA1259073A (en) 1989-09-05
ES8607270A1 (es) 1986-05-16
US4668691A (en) 1987-05-26
EP0160256A3 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
DK368287D0 (da) Substituerede amino-5,6,7,8-tetrahydronaphthyloxy-eddikesyrer, fremgangsmaader til deres fremstilling og deres anvendelse som laegemidler
IT8648487A0 (it) Dispositivi perfezionati per l'impianto di strutture di lenti intraoculari
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
FI820529L (fi) Bispidinderivat, deras framstaellning och dessa innehaollande laekemedel
FI831388L (fi) 2-/2'-hydroxi-3'-(1,1-dimetylpropylamino)-propoxi/- -fenylpropionfenon, syreadditionssalter av denna foerfarande foer framstaellning av denna och farmaceutiska sammansaettningar
DK23386A (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
ES551451A0 (es) Procedimiento para la obtencion de furanonas.
IL68612A (en) 2-aryltetraazaindenes,their preparation and pharmaceutical compositions containing them
DK407885D0 (da) 7-(2-(dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-oner
SE8704979L (sv) Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
FI870067A (fi) Metionin-substituerade 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning.
DK162738C (da) Varmesteriliserbart kunstigt organ til blodrensning
FR2374336A1 (fr) Nouveaux derives acyles de l'hellebrigenine
DK420187A (da) Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse
ES2051773T3 (es) Procedimiento para la obtencion de aralquil-4h,1,2,4-triazil derivados.
ATE17945T1 (de) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepin , ihre herstellung und verwendung.
SE8603517L (sv) Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar
DK0481253T3 (da) Nye p-oxybenzoesyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK300583A (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
IT1157025B (it) Protesi valvolare cardiaca particolarmente per la sostituzione della valvola mitrale umana

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603